Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner
Jong Woo Kim, Min-Ju Kim, Tae-Hee Han, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 24

Showing 24 citing articles:

Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 20
Exploiting ferroptosis vulnerabilities in cancer
Toshitaka Nakamura, Marcus Conrad
Nature Cell Biology (2024) Vol. 26, Iss. 9, pp. 1407-1419
Closed Access | Times Cited: 16
MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
Xing Luo, Yuehong Wang, Xinxin Zhu, et al.
Redox Biology (2023) Vol. 69, pp. 102987-102987
Open Access | Times Cited: 26
FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications
Ran Gao, Jinge Wang, Jingjing Huang, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1019-1037
Closed Access | Times Cited: 8
Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors
Carolina Punziano, Silvia Trombetti, Elena Cesaro, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 298-298
Open Access | Times Cited: 7
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 6
Ferroptosis-related signaling pathways in cancer drug resistance
Yang Yang‐Hartwich, Simin Yu, Wanyao Liu, et al.
Cancer Drug Resistance (2025) Vol. 8, Iss. 1
Open Access
Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker
Xinguo Zhang, Wenting Li, Xin Jin, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 276-276
Open Access
NFE2L2 and ferroptosis resistance in cancer therapy
Daolin Tang, Rui Kang
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Sodium aescinate induces renal toxicity by promoting Nrf2/GPX4-mediated ferroptosis
Haiyan Zhu, Yenan Duan, Yijing Yang, et al.
Chemico-Biological Interactions (2024) Vol. 391, pp. 110892-110892
Closed Access | Times Cited: 4
Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis
Xiangpeng Meng, Fang Peng, Shijie Yu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 3
Matrine induces cardiotoxicity by promoting ferroptosis through the Nrf2 antioxidant system in H9c2 cells
Xi Wang, Zixiong Lin, Xinyi Tang, et al.
Toxicology Letters (2024) Vol. 397, pp. 11-22
Closed Access | Times Cited: 3
Ferroptosis as an emerging target in sickle cell disease
Vitor Fortuna, Jaqueline Costa Lima, Gabriel F. Oliveira, et al.
Current Research in Toxicology (2024) Vol. 7, pp. 100181-100181
Open Access | Times Cited: 3
Ferroptosis regulation by Cap’n’collar family transcription factors
Magdalena Murray, Scott J. Dixon
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107583-107583
Open Access | Times Cited: 3
Nrf2/FSP1/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity
Haiyan Zhu, Yijing Yang, Yenan Duan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110100-110100
Closed Access | Times Cited: 2
Nrf2 in human cancers: biological significance and therapeutic potential
Yu Tian, Lixin Tang, Xin Wang, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 3935-3961
Closed Access | Times Cited: 2
Targeting ferroptosis opens new avenues in gliomas
Yuxin Wei, Yang Xu, Qian Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4674-4690
Open Access | Times Cited: 1
The suppression of FSP1 expression via NRF2 promotes ferroptosis induced by reactive oxygen species in vascular smooth muscle cells
Zhongcheng Xie, Jiamin Guo, Yunong Deng, et al.
Process Biochemistry (2024) Vol. 143, pp. 277-291
Closed Access
Enhancement of Breast Cancer Chemotherapy and Radiotherapy Responses by Modulation of Ferroptosis
Alaa A.M. Al-Zufairi
(2024)
Open Access
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent Genes
Leoni Lorenz, Tamara Zenz, Denys Oliinyk, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1080-1080
Open Access
Responsive Plasmonic Hybrid Nanorods Enables Metabolism Reprogramming via Cuproptosis-Photothermal Combined Cancer Therapy
Qian Xie, Tao Sun, Wei Zhang, et al.
Biomaterials (2024) Vol. 315, pp. 122971-122971
Closed Access
Mechanism of ferroptosis resistance in cancer cells
Yuan Wang, Guifang Yu, Xin Chen
Cancer Drug Resistance (2024)
Open Access
Splicing junction-based classifier for the detection of abnormal constitutive activation of the KEAP1-NRF2 system
Raúl Nicolás Mateos, Wira Winardi, Kenichi Chiba, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access
Cell-membrane Targeting Sonodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis-Boosted Immunotherapy
Jian Chen, Qiyu Zhan, Lie Li, et al.
Materials Today Bio (2024) Vol. 30, pp. 101407-101407
Open Access
Page 1

Scroll to top